![Bioequivalence of Sandoz methylphenidate osmotic‐controlled release tablet with Concerta® (Janssen‐Cilag) - Schapperer - 2015 - Pharmacology Research & Perspectives - Wiley Online Library Bioequivalence of Sandoz methylphenidate osmotic‐controlled release tablet with Concerta® (Janssen‐Cilag) - Schapperer - 2015 - Pharmacology Research & Perspectives - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/7c04a3ee-5c6a-4757-81f3-e3fda99ba51d/prp272-fig-0001-m.jpg)
Bioequivalence of Sandoz methylphenidate osmotic‐controlled release tablet with Concerta® (Janssen‐Cilag) - Schapperer - 2015 - Pharmacology Research & Perspectives - Wiley Online Library
![Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-244X-13-237/MediaObjects/12888_2013_Article_1428_Fig4_HTML.jpg)
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text
![Therapeutics Initiative | OROS methylphenidate (Concerta) for the treatment of children and adults with ADHD Therapeutics Initiative | OROS methylphenidate (Concerta) for the treatment of children and adults with ADHD](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2011/05/ti_feature.png)
Therapeutics Initiative | OROS methylphenidate (Concerta) for the treatment of children and adults with ADHD
![These highlights do not include all the information needed to use CONCERTA® safely and effectively. See full prescribing information for CONCERTA®. CONCERTA® (methylphenidate HCl) Extended-Release Tablets CIIInitial U.S. Approval: 2000 These highlights do not include all the information needed to use CONCERTA® safely and effectively. See full prescribing information for CONCERTA®. CONCERTA® (methylphenidate HCl) Extended-Release Tablets CIIInitial U.S. Approval: 2000](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=concerta-04.jpg&id=35338)
These highlights do not include all the information needed to use CONCERTA® safely and effectively. See full prescribing information for CONCERTA®. CONCERTA® (methylphenidate HCl) Extended-Release Tablets CIIInitial U.S. Approval: 2000
![WO2015188092A1 - Methods for treating attention deficit hyperactivity disorder with methylphenidate - Google Patents WO2015188092A1 - Methods for treating attention deficit hyperactivity disorder with methylphenidate - Google Patents](https://patentimages.storage.googleapis.com/41/da/cb/6f19b2a8a8b76a/imgf000030_0001.png)